Viewing Study NCT02051218


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-02-25 @ 10:13 PM
Study NCT ID: NCT02051218
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-13
First Post: 2014-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
Sponsor:
Organization: